[HTML][HTML] KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
CY Li, W Wang, CH Leung, GJ Yang, J Chen - Molecular Cancer, 2024 - Springer
Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
[PDF][PDF] KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
CY Li, W Wang, CH Leung, GJ Yang, J Chen - 2024 - researchgate.net
Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
[HTML][HTML] KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
CY Li, W Wang, CH Leung, GJ Yang, J Chen - Molecular Cancer, 2024 - ncbi.nlm.nih.gov
Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
CY Li, W Wang, CH Leung, GJ Yang… - Molecular …, 2024 - pubmed.ncbi.nlm.nih.gov
Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
[HTML][HTML] KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
CY Li, W Wang, CH Leung… - Molecular …, 2024 - molecular-cancer.biomedcentral …
Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
CY Li, W Wang, CH Leung, GJ Yang… - Molecular …, 2024 - search.ebscohost.com
Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges.
CY Li, W Wang, CH Leung, GJ Yang, J Chen - Molecular Cancer, 2024 - europepmc.org
Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
[PDF][PDF] KDM5 family as therapeutic targets in breast cancer: Pathogenesis and therapeutic opportunities and challenges
CY Li, W Wang, CH Leung, GJ Yang, J Chen - 2024 - molecular-cancer.biomedcentral …
Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …
for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) …